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Summary 
Suborbital space platforms provide a unique 
opportunity for Space Life Sciences in the next few 
years.  The opportunities include:  physiological 
characterization of the first few minutes of space 
flight; evaluation of a wide-variety of medical 
conditions during periods of hyper and hypo-gravity 
through physiological monitoring; and evaluation of 
new biomedical and environmental health 
technologies under hyper and hypo-gravity 
conditions. 
 
Introduction 
At the present time, very little is known about the 
physiological consequences of the first few 
minutes of space flight under hyper-gravity 
followed by hypo-gravity exposures.  Since many 
individuals will fly under similar conditions, large 
data sets can be acquired if the appropriate pre- 
and post-flight data is collected along with focused 
in-flight data collection of physiological 
parameters.  Current long-duration flight 
operations do not permit the evaluation of novel 
technologies with redesign and reflight in short 
periods of time. 
 
Approach 
Pre- and post- flight data collection can be 
acquired through the medical examinations 
performed by the various commercial space flight 
operators.  Ideally a centralized database of these 
data will be collected in a non-attributable manner 
so that group data can be analyzed for the benefit 
of all future passengers and operators.  In-flight 
data can be collected by very sophisticated 
biomedical and environmental equipment that can 
collect samples with non or minimally invasive 
methods.  High data rate collection would be 
preferred to capture physiological variations during 
short exposures.  Since many individuals will fly 
with medical conditions not before flown in space 
via government space operations, various 
passenger cohorts can be established to 
accurately determine the response of a wide-
range of medical problems under hyper- and hypo-
gravity exposures.  These data can then be 
utilized to determine risk-management by the 
operators, inform medical standards for crew of 
commercial space vehicles and government space 
operations, and to suggest future areas of 
research during longer duration government space 
operations such as the International Space Station 
(ISS). 
 
Novel technologies to provide biomedical 
diagnostic and therapeutic monitoring can be 
assessed for their performance during suborbital 
operations.  Since flights can be repeated at 
frequent intervals, equipment can be tested, data 
evaluated, operational changes performed and 
equipment reflown in short periods of time. This 
adaptive design capability allows rapid prototyping, 
test/evaluation, and redesign in short periods of 
time, and may permit  the more rapid development 
and flight certification of novel technologies.  These 
technologies may therefore be more robust when 
considered for longer duration space flight by 
government space operations with flight durations 
of weeks or months. 
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